Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

LTR Pharma’s pivotal trial for its novel intranasal formulation SPONTAN demonstrates it outperforms traditional oral erectile ...

Indian stock markets poised for a positive start on Monday, driven by global gains and strong sector performance. Sensex and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and ...

Tourmaline Bio's Pacibekitug shows promise in treating thyroid eye disease. Read why I think TRML stock is a strong buy.

A t the moment, CRISPR Therapeutics (NASDAQ: CRSP) is in a special period that most biotechs never survive to reach. Small ...

While momentum from the gene-editing therapy will take time to manifest on the top and bottom lines, analysts think that Casgevy will bring in an additional $3 billion or more annually for Vertex in ...

Cancer drug developer gets much-needed funds, plus Clarity launches cancer diagnosis trial and LTR delivers ED spray trial ...

The outcome of the 2024 U.S. presidential election is poised to affect the biotechnology sector, as both major parties present policy proposals that could reshape drug pricing, regulation, and ...

He says the sector offers one of the best opportunities as IT spends in BFSI companies is picking up, and tier 1 companies ...

Gireesh Babu, New Delhi Monday, October 14, 2024, 08:00 Hrs [IST] ...